Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 249

1.

Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol.

Chen JT, Wesley R, Shamburek RD, Pucino F, Csako G.

Pharmacotherapy. 2005 Feb;25(2):171-83. Review.

PMID:
15767233
2.

The comparative efficacy of plant sterols and stanols on serum lipids: a systematic review and meta-analysis.

Talati R, Sobieraj DM, Makanji SS, Phung OJ, Coleman CI.

J Am Diet Assoc. 2010 May;110(5):719-26. doi: 10.1016/j.jada.2010.02.011. Review.

PMID:
20430133
3.

The effect of adding plant sterols or stanols to statin therapy in hypercholesterolemic patients: systematic review and meta-analysis.

Scholle JM, Baker WL, Talati R, Coleman CI.

J Am Coll Nutr. 2009 Oct;28(5):517-24. Review.

PMID:
20439548
4.

Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.

Castaño G, Fernández L, Mas R, Illnait J, Gámez R, Mendoza S, Mesa M, Fernández J.

Drugs R D. 2005;6(4):207-19.

PMID:
16050054
5.

Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.

Castaño G, Mas R, Fernández L, Illnait J, Gámez R, Alvarez E.

Int J Clin Pharmacol Res. 2001;21(1):43-57.

PMID:
11708574
6.
7.

Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.

Castaño G, Menéndez R, Más R, Amor A, Fernández JL, González RL, Lezcay M, Alvarez E.

Int J Clin Pharmacol Res. 2002;22(3-4):89-99.

PMID:
12837046
8.

The effect of plant sterols or stanols on lipid parameters in patients with type 2 diabetes: a meta-analysis.

Baker WL, Baker EL, Coleman CI.

Diabetes Res Clin Pract. 2009 May;84(2):e33-7. doi: 10.1016/j.diabres.2009.01.015. Epub 2009 Feb 24.

PMID:
19243852
9.

Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women.

Mirkin A, Mas R, Martinto M, Boccanera R, Robertis A, Poudes R, Fuster A, Lastreto E, Yañez M, Irico G, McCook B, Farré A.

Int J Clin Pharmacol Res. 2001;21(1):31-41.

PMID:
11708573
10.

Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease.

Gylling H, Plat J, Turley S, Ginsberg HN, Ellegård L, Jessup W, Jones PJ, Lütjohann D, Maerz W, Masana L, Silbernagel G, Staels B, Borén J, Catapano AL, De Backer G, Deanfield J, Descamps OS, Kovanen PT, Riccardi G, Tokgözoglu L, Chapman MJ; European Atherosclerosis Society Consensus Panel on Phytosterols.

Atherosclerosis. 2014 Feb;232(2):346-60. doi: 10.1016/j.atherosclerosis.2013.11.043. Epub 2013 Nov 23. Review.

11.

Concomitant use of policosanol and beta-blockers in older patients.

Castaño G, Mas R, Gámez R, Fernández J, Illnait J, Fernández L, Mendoza S, Mesa M, Gutiérrez JA, López E.

Int J Clin Pharmacol Res. 2004;24(2-3):65-77.

PMID:
15689053
12.
13.

Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.

Castaño G, Más R, Arruzazabala ML, Noa M, Illnait J, Fernández JC, Molina V, Menéndez A.

Int J Clin Pharmacol Res. 1999;19(4):105-16.

PMID:
10939028
14.

History and development of plant sterol and stanol esters for cholesterol-lowering purposes.

Thompson GR, Grundy SM.

Am J Cardiol. 2005 Jul 4;96(1A):3D-9D.

PMID:
15992509
15.

Plant sterols and stanols.

Tikkanen MJ.

Handb Exp Pharmacol. 2005;(170):215-30. Review.

PMID:
16596801
16.

Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.

Crespo N, Illnait J, Más R, Fernández L, Fernández J, Castaño G.

Int J Clin Pharmacol Res. 1999;19(4):117-27.

PMID:
10939029
17.

Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels.

Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R; Stresa Workshop Participants.

Mayo Clin Proc. 2003 Aug;78(8):965-78. Review.

PMID:
12911045
18.

Comparison of the efficacy, safety and tolerability of original policosanol versus other mixtures of higher aliphatic primary alcohols in patients with type II hypercholesterolemia.

Castaño G, Fernández L, Mas R, Illnait J, Fernández J, Mesa M, Alvarez E, Lezcay M.

Int J Clin Pharmacol Res. 2002;22(2):55-66.

PMID:
12503776
19.

Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk.

Castaño G, Más R, Fernández JC, Illnait J, Fernández L, Alvarez E.

J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M186-92.

PMID:
11253161
20.

Effects of policosanol on postmenopausal women with type II hypercholesterolemia.

Castaño G, Más R, Fernández L, Fernández JC, Illnait J, López LE, Alvarez E.

Gynecol Endocrinol. 2000 Jun;14(3):187-95.

PMID:
10923280

Supplemental Content

Support Center